[{"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78404", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0072-2018", "product_description": "Doan's Pain Relieving Cream with 4% Lidocaine Plus Menthol, (lidocaine 4%, menthol 1%), Net Wt. 2.75 oz. (77.3 g) Tube, Distributed by: Ducere Pharma, LLC New Hope, PA 18938 USA --- UPC 849648000023", "product_quantity": "23402 cases", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date; lot number on the secondary packaging doesn\u0019t match the lot number printed on the bottle", "recall_initiation_date": "20171030", "center_classification_date": "20171107", "termination_date": "20200320", "report_date": "20171115", "code_info": "lots #2462100R, Exp 11/2018; 2583800R, Exp 09/2018"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-067-2014", "product_description": "Carnitine 250mg/ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "30 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212969"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-520", "68462-521"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["1807888", "1807915"], "spl_id": ["ef160cca-85e2-440c-997f-0535914b4d3f"], "spl_set_id": ["0ef9de1a-b786-4b6c-a250-3f5ac532b16a"], "package_ndc": ["68462-520-01", "68462-520-05", "68462-520-10", "68462-521-90", "68462-521-01", "68462-521-05"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0328-2025", "product_description": "Metformin Hydrochloride Extended-Release Tablets 1000mg, 90-count bottle. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC 68462-521-90.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232088, exp. date Sep-25 17232093, exp. date Sep-25"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020178"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0553"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807631", "1807632"], "spl_id": ["aca96e4a-a57b-47ac-bd60-e65c29e19743"], "spl_set_id": ["fbc01464-8885-4075-af41-911ffec5ae92"], "package_ndc": ["0338-0553-11", "0338-0553-18"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "69962", "recalling_firm": "Baxter Healthcare Corp", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-481-2015", "product_description": "0.9% Sodium Chloride Injection USP, 100 mL MINI-BAG Plus Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL  60015, USA, Product Code 2B0043, NDC 0338-0553-18.", "product_quantity": "542,080 container bags", "reason_for_recall": "Presence of Particulate Matter: Confirmed customer  complaints received for the presence of blue plastic,  identified as fragments of the frangible from the vial adapter.", "recall_initiation_date": "20141204", "center_classification_date": "20150408", "termination_date": "20170414", "report_date": "20150415", "code_info": "Lot #: P317891, P317842, Exp 05/15"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0671-2023", "product_description": "Cardioplegia Solution, Maintenance 4:1 in Ringer's, low potassium, 12 mEq K, packaged in 504.8 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0205-1.", "product_quantity": "280 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-894325, Exp 04/29/2023; 37-895211, Exp 05/04/2023; 37-899265, Exp 05/19/2023"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94888", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0611-2024", "product_description": "Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1203-03", "product_quantity": "142 blister cards, 30 per blister card", "reason_for_recall": "CGMP Deviations: Out of specification for dissolution", "recall_initiation_date": "20240626", "center_classification_date": "20240718", "termination_date": "20250131", "report_date": "20240724", "code_info": "Lot #: J0758674-021824, Exp 03/31/2025; J0751898-011424, Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0148-2025", "product_description": "Henry Schein, Benzo-Jel, Topical Anesthetic Gel, 20% Benzocaine, 1 fl. oz. (29.6 mL), Distributed by Henry Schein, Melville, NY 11747, For Professional Use Only,", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-43619", "more_code_info": ""}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86833", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Canada", "recall_number": "D-0156-2021", "product_description": "RiteAid Pharmacy RIngworm Cream, Clotrimazole Cream USP, 1%, Antifungal NET W 0.5 oz. (14.2g), Distributed by: Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011 Made in Canada. UPC 0 11822 53812 1", "product_quantity": "34,920 0.5 oz tubes", "reason_for_recall": "Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.", "recall_initiation_date": "20201117", "center_classification_date": "20201216", "termination_date": "20240221", "report_date": "20201223", "code_info": "Lot#: A873630559, Exp Dec 2020."}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80828", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1132-2018", "product_description": "Valsartan Tablets, USP 160 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-785-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478", "product_quantity": "818 cartons (40,900 tablets)", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180814", "center_classification_date": "20180828", "termination_date": "20200507", "report_date": "20180905", "code_info": "Lots: 17717 Exp. 07/2018; 18493 Exp. 01/2019; 19761 Exp. 04/2019"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0742-2023", "product_description": "EPINEPHrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-8093-1.", "product_quantity": "8171 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-882988, Exp 04/28/2023; 37-883194, 37-883208, Exp 04/30/2023; 37-884746, Exp 05/05/2023; 37-885215, Exp 05/08/2023; 37-885927, Exp 05/10/2023; 37-887044, 37-887051, Exp 05/15/2023; 37-887667, Exp 05/17/2023; 37-888297, 37-888298, Exp 05/21/2023; 37-890886, Exp 05/30/2023; 37-891438, Exp 06/01/2023; 37-892497, Exp 06/06/2023; 37-893159, Exp 06/08/2023; 37-893843, Exp 06/12/2023; 37-894649, Exp 06/14/2023; 37-896928, Exp 06/22/2023; 37-899304, Exp 07/03/2023"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA040078"], "brand_name": ["LIDOCAINE HYDROCHLORIDE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-2066"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INFILTRATION", "INTRACAUDAL", "PERINEURAL"], "substance_name": ["LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1737761"], "spl_id": ["7ec189f1-7357-4bc2-b1d3-57cbb695252d"], "spl_set_id": ["9c18eaf1-4a0b-4916-70b2-88a827494711"], "package_ndc": ["0409-2066-10", "0409-2066-05"], "is_original_packager": [true], "unii": ["V13007Z41A"]}, "product_type": "Drugs", "event_id": "67140", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1278-2014", "product_description": "Lidocaine HCl  Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only,  Hospira, Inc., Lake Forest, IL. 60045, NDC 0409-2066-05.", "product_quantity": "68,350 vials", "reason_for_recall": "Presence of Particulate Matter- Confimed customer complaint of  particulates embedded in glass container and in contact with product solution.", "recall_initiation_date": "20131223", "center_classification_date": "20140427", "termination_date": "20141007", "report_date": "20140507", "code_info": "Lot 32135DD; Exp 08/15", "more_code_info": ""}, {"status": "Terminated", "city": "Murray", "state": "UT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71989", "recalling_firm": "Novacare, LLC", "address_1": "312 W 6100 S", "address_2": "N/A", "postal_code": "84107-6990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0961-2016", "product_description": "Thin and Slim Fataway Ultimate Stack with Chromium, packaged per 120 capsules.  Distributed by Dale H Enterprises Inc. Lewisburg, PA 17837, www.fataway.org.", "product_quantity": "N/A", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid  in dietary supplements.", "recall_initiation_date": "20150824", "center_classification_date": "20160606", "termination_date": "20170830", "report_date": "20160615", "code_info": "UPC 853002003025"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "887 cases", "code_info": "Product Code: 6173; Lots:  57899, EXP 09/19/2017; 58919, EXP 11/15/2017; 60058, EXP 01/08/2018; 61135, EXP 03/05/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Oral Care Suction Toothbrushes with Antiseptic Oral Rinse and Mouth Moisturizer, Contains 2 Suction Toothbrushes with sodium bicarbonate. 0.25 fl oz/7ml Antiseptic Oral Rinse, 0.07 oz/2g Mouth Moisturizer, Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6173", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0370-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "50 vials", "code_info": "Lot #: Taurine 50 mg/mL: 20130305-A, Exp 6/5/2013; Taurine-50-30 mL: 20130123-D, Exp 4/23/2013; Taurine-50mg-30 mL: 21030117-J, Exp 4/17/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Taurine Injection, all strengths and all presentations including a) Taurine 50 mg/mL, b) Taurine-50-30 mL, c) Taurine-50 mg-30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-411-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; QUINAPRIL HCL, Tablet, 20 mg may be potentially mislabeled as    MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 65162066850, Pedigree: W003553, EXP: 6/24/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "QUINAPRIL HCL, Tablet, 20 mg has the following code    Pedigree: W003556, EXP: 6/24/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "QUINAPRIL HCL, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 68180055809", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-724-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0213-2016", "product_description": "E2 (Estradiol (E2) Trit (Yellow) : E3 (Estriol USP Micronized (E3)  : PROGEST (Progesterone USP Micronized) : TESTOST (Testosterone USP)  IN OLIVE OIL 0.75 : 3 : 50 : 5MG capsules, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "120 capsules", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 02172015:64@24, Exp 5/18/2015"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-582-2015", "product_description": "Cholestyramine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "7750 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 120"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-328"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["208545", "1923809"], "spl_id": ["b12c988d-27b2-4548-83c0-a6837ada2db3"], "spl_set_id": ["00046231-8fab-44a0-b986-9a9dd450881d"], "package_ndc": ["42192-328-30", "42192-328-01", "42192-328-07"], "is_original_packager": [true], "upc": ["0342192328013"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0399-2021", "product_description": "NP Thyroid 120 Thyroid Tablets, USP 2 grain (120 mg), packaged in a) 100-count bottles (NDC 42192-328-01) and b) 7-count bottles (NDC 42192-328-07) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005", "product_quantity": "a) 69,289 bottles; b) 9,076 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lot #: a) M328H19-2B, M328J19-11, M328J19-2A, M328J19-3A, M328J19-4A M328J19-5A, M328J19-6A, M328J19-7A, Exp. 08/31/2021, M328K19-2,  M328K19-4A, Exp. 09/30/2021; b) M328J19-9B Exp. 08/31/2021"}, {"status": "Terminated", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78991", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "N/A", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed U.S.A. nationwide.", "recall_number": "D-0328-2018", "product_description": "Tationil Glutathione, 600 mg/ 4 mL, polvere e solvente per soluzione iniettabile, Teofarma, s.r.l.", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.", "recall_initiation_date": "20180119", "center_classification_date": "20180205", "termination_date": "20180913", "report_date": "20180214", "code_info": "all lots"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90774", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Distributed Nationwide in the USA to the following States: AZ, CA, GA, ID, IN, MT, NM, NV, OR, TX, UT", "recall_number": "D-1465-2022", "product_description": "Colgate Anticavity Fluoride Toothpaste, OPTIC WHITE PRO SERIES, Stain Prevention, 5% Hydrogen Peroxide, Net Wt. 2.1 OZ. (59 g) UPC 0 35000 99658 9. Dist. by: Colgate-Palmolive Company New York, NY 10022 U.S.A.", "product_quantity": "1120 packages", "reason_for_recall": "cGMP deviation: Product held outside of appropriate temperature storage conditions.", "recall_initiation_date": "20220810", "center_classification_date": "20220829", "report_date": "20220907", "code_info": "SKUs 998277 distributed to Family Dollar retail stores in AZ, CA, GA, ID, IN, MT, NM, NV, OR, TX, UT", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0965-2020", "product_description": "Methionine/Inositol/Choline Injection, METHIONINE/INOSITOL/CHOLINE 25MG/50MG/50MG/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0215-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 09052019+52881, Exp 4/7/2020; 09302019+52977, Exp 5/2/2020; 10072019+53049, Exp 5/9/2020"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71618", "recalling_firm": "The Apothecary Shoppe LLC", "address_1": "6136 E 51st St", "address_2": "N/A", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Oklahoma", "recall_number": "D-1290-2015", "product_description": "S-Chorionic Gonad HCG 1000 U/mL Injection, Rx Only, 4 mL Vial, Apothecary Shoppe, Compounding Pharmacy, Tulsa OK 74135, NDC 14294-1968-80", "product_quantity": "98 mL", "reason_for_recall": "Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced.", "recall_initiation_date": "20150626", "center_classification_date": "20150806", "termination_date": "20170217", "report_date": "20150812", "code_info": "Lot #: 04302015@66, BUD 06/29/2015"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1616-2019", "product_description": "Stomach Flu Capsules, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76933", "recalling_firm": "InnovaGel", "address_1": "14193 Sw 119th Ave", "address_2": "N/A", "postal_code": "33186-6013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "NY only", "recall_number": "D-0675-2017", "product_description": "Dye Free Allergy Softgel Gelatin Capsule, 15,000-count bulk drums, aenova/Swiss Caps USA, Inc., 14193 S.W. 119th Avenue, Miami, FL  33186, Product Code MSU0067P, NDC 6897080284", "product_quantity": "9,992,768 softgels", "reason_for_recall": "Subpotent", "recall_initiation_date": "20170105", "center_classification_date": "20170419", "termination_date": "20210929", "report_date": "20170426", "code_info": "Batch #: 1508803,1602801, 1602802, 1604801, 1604802, 1606801, 1606802, 1606803, 1606804, Exp. 08/03/2018."}, {"country": "United States", "city": "North Miami Beach", "address_1": "3660 NE 166th St.", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine", "address_2": "Apt. 606", "product_quantity": "10 bottles", "code_info": "ALL LOTS", "center_classification_date": "20140414", "distribution_pattern": "Nationwide", "state": "FL", "product_description": "Slim Fortune capsules Dietary Supplement. Each bottle contains 30 capsules.", "report_date": "20140423", "classification": "Class I", "openfda": {}, "recalling_firm": "B @ B Trade Inc.", "recall_number": "D-1231-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "66469", "termination_date": "20191002", "recall_initiation_date": "20131007", "postal_code": "33160", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0553-2017", "product_description": "CLARIFYING CREAM (Retinoic acid 0.025%, Salicylic Acid 1%, Green tea powder, Ascorbic acid 2%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0366-2016", "product_description": "B12 Injection 12.5/12.5MG, 3mL, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "98 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94975", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0618-2024", "product_description": "Complete 30C/200C Homeopathic Kit, Contains: One hundred 1/2 dram vials of homeopathic medicines, Washington Homeopathic Products, Inc., Berkley Springs, WV 25411, UPC 7 40640 64300 6.", "product_quantity": "11 kits", "reason_for_recall": "Labeling: Label Mix-up: Some bottles of Ferrum Phosphoricum 200C were incorrectly labeled as Ferrum Metallicum 200C.", "recall_initiation_date": "20240531", "center_classification_date": "20240725", "termination_date": "20240918", "report_date": "20240731", "code_info": "lot #: 32093, Exp. 8/31/2028", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0146-2025", "product_description": "Quala Dental Products, Topical Anesthetic Gel, Contains 20% Benzocaine, Net Contents: 1 oz (30g), Gluten Free, Quala Dental Products, Made in USA for: NDC, Inc, 407 New Sanford Road, La Vergne, TN 37086, www.quala.com", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot No.: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-64419", "more_code_info": ""}, {"status": "Terminated", "city": "Rocky Mount", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77533", "recalling_firm": "Hospira a Pfizer Company", "address_1": "4285 N Wesleyan Blvd", "address_2": "N/A", "postal_code": "27804-8612", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore", "recall_number": "D-1047-2017", "product_description": "8.4% Sodium Bicarbonate Inj., USP 50 mL Single-dose, 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL), Rx Only,  Mfd by Hospira, INC, Lake Forest, IL 60045 USA,  NDC: 0409-6625-02", "product_quantity": "91,483,150 50 mL single dose vials", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20170615", "center_classification_date": "20170801", "termination_date": "20200720", "report_date": "20170809", "code_info": "Lot: 72109EV Exp. 12/01/2018, Lot: 72110EV Exp. 12/01/2018,  Lot: 72112EV Exp. 12/01/2018, Lot: 72113EV Exp. 12/01/2018, Lot: 72114EV Exp. 12/01/2018, Lot: 73068EV Exp. 01/01/2019, Lot: 73071EV Exp. 01/01/2019, Lot: 73072EV Exp. 01/01/2019, Lot: 73224EV Exp. 01/01/2019, Lot: 73225EV Exp. 01/01/2019, Lot: 73230EV Exp. 01/01/2019, Lot: 73231EV Exp. 01/01/2019, Lot: 73232EV Exp. 01/01/2019, Lot: 73233EV Exp. 01/01/2019, Lot: 73234EV Exp. 01/01/2019, Lot: 73235EV Exp. 01/01/2019, Lot: 73236EV Exp. 01/01/2019, Lot: 73298EV Exp. 01/01/2019, Lot: 74058EV Exp. 02/01/2019, Lot: 74104EV Exp. 02/01/2019, Lot: 74105EV Exp. 02/01/2019, Lot: 74106EV Exp. 02/01/2019, Lot; 74107EV Exp. 02/01/2019, Lot: 74197EV Exp. 02/01/2019, Lot: 74198EV Exp. 02/01/2019, Lot: 74199EV Exp. 02/01/2019, Lot: 74200EV Exp. 02/01/2019, Lot: 74201EV Exp. 02/01/2019, Lot: 75171EV Exp. 03/01/2019, Lot: 75172EV Exp. 03/01/2019, Lot: 75173EV Exp. 03/01/2019, Lot: 75174EV Exp. 03/01/2019, Lot: 75175EV Exp. 03/01/2019, Lot: 75176EV Exp. 03/01/2019, Lot: 75177EV Exp. 03/01/2019, Lot: 75178EV Exp. 03/01/2019. Lot: 75293 Exp. 03/01/2019, Lot: 75418EV Exp. 03/01/2019, Lot: 75419EV Exp. 03/01/2019"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0237-2016", "product_description": "Alprostadil (PGE-1), 5 mL (40 mcg/mL) in 10 mL Multi-Dose Vial, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC: 62295-3253-05.", "product_quantity": "82 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20150408@10 BUD: 1/27/2015; 20151407@11 BUD: 1/10/2015; 20151604@8 9/16/2015; 20152703@2 9/16/2015"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065259"], "brand_name": ["CEFDINIR"], "generic_name": ["CEFDINIR"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-722", "68180-723"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFDINIR"], "rxcui": ["309054", "476576"], "spl_id": ["b32b7bfb-4770-4da0-8c48-684233cd10c9"], "spl_set_id": ["7490df67-56c0-4a1c-8533-2107f3e8aea5"], "package_ndc": ["68180-722-20", "68180-722-10", "68180-722-04", "68180-722-05", "68180-723-20", "68180-723-10", "68180-723-04", "68180-723-05"], "is_original_packager": [true], "upc": ["0368180723042"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["CI0FAO63WC"]}, "product_type": "Drugs", "event_id": "79612", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0684-2018", "product_description": "Lupin Cefdinir powder  for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs ( 68180-723-10), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202", "product_quantity": "40,824 bottles", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20180327", "center_classification_date": "20180417", "termination_date": "20190415", "report_date": "20180425", "code_info": "Lot # F602241; Exp. 10/18  Lot # F602577; Exp. 11/18  Lot # F700036; Exp. 12/18", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-424-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles (NDC 60793-853-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "112,914 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 64935, Exp. 5/13; 65239, Exp. 6/13; 65900, Exp. 8/13; 66370, Exp. 10/13; and 66391, Exp. 9/13; b) 64927, Exp. 5/13; and 65240, Exp. 6/13"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207687"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-044", "16729-045", "16729-046", "16729-047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["40828d2e-69eb-5d38-e063-6394a90abd70"], "spl_set_id": ["4e06b20d-cc5d-46eb-991b-5972248de3af"], "package_ndc": ["16729-045-10", "16729-045-15", "16729-045-01", "16729-045-16", "16729-045-17", "16729-044-10", "16729-044-15", "16729-044-01", "16729-044-16", "16729-044-17", "16729-046-10", "16729-046-15", "16729-046-01", "16729-046-16", "16729-046-17", "16729-047-10", "16729-047-15", "16729-047-01", "16729-047-16", "16729-047-17"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"], "upc": ["316729046152", "316729046176"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0373-2023", "product_description": "Atorvastatin Calcium Tablets USP 40 mg* Rx Only, Packaged as a) 90 Tablets NDC 16729-046-15 UPC 3 16729 04615 2; b) 1,000 Tablets NDC 16729-046-17 UPC 3 16729 04617 6,  Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "147,736 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a)R2100552, R2100553, Exp. Date 4/30/2023; R2200253, Exp. Date 2/29/2024; R2200627, Exp. Date 4/30/2024; R2201113, Exp. Date 6/30/2024; R2201184, Exp. Date 8/31/2024; R2201366, Exp. Date 9/30/2024;  b) R2200280, Exp. Date 2/29/2024; R2200385, R2200386, R2200491, R2200490, R2200494, R2200496, R2200495, Exp. Date 3/31/2024; R2200510, R2200520, R2200521, R2200517, R2200511, R2200632, R2200631, R2200637, R2200635, R2200648, R2200638, R2200639, R2200647, Exp. Date 4/30/2024; R2200727, Exp. Date 5/31/2024;", "more_code_info": ""}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "Ye Lang Shen capsules, 5000 mg, 8-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class II", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0561-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91952", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0526-2023", "product_description": "Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7", "product_quantity": "32 Bottles", "reason_for_recall": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.", "recall_initiation_date": "20230323", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "Lot: C0822E, Exp 1/31/2024, F1121B, Exp 1/31/2024, G2721L, Exp 1/31/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040616"], "brand_name": ["WARFARIN SODIUM"], "generic_name": ["WARFARIN SODIUM"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-1712", "0093-1713", "0093-1714", "0093-1715", "0093-1716", "0093-1721", "0093-1718", "0093-1723", "0093-1720"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["WARFARIN SODIUM"], "rxcui": ["855288", "855296", "855302", "855312", "855318", "855324", "855332", "855338", "855344"], "spl_id": ["b8c33971-54b3-4971-bf7f-1bec66999a29"], "spl_set_id": ["0cbce382-9c88-4f58-ae0f-532a841e8f95"], "package_ndc": ["0093-1712-01", "0093-1712-10", "0093-1713-01", "0093-1713-10", "0093-1714-01", "0093-1714-10", "0093-1715-01", "0093-1716-01", "0093-1716-10", "0093-1721-01", "0093-1721-10", "0093-1718-01", "0093-1723-01", "0093-1720-01"], "is_original_packager": [true], "upc": ["0300931721013", "0300931713018", "0300931714015", "0300931723017", "0300931716019", "0300931715012"], "unii": ["6153CWM0CL"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0201-2024", "product_description": "Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054.  NDC:  0093-1721-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 2323041", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017512"], "brand_name": ["DIANEAL LOW CALCIUM WITH DEXTROSE"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"], "manufacturer_name": ["Vantive US Healthcare LLC"], "product_ndc": ["0941-0409", "0941-0411", "0941-0413", "0941-0415", "0941-0457", "0941-0459", "0941-0426", "0941-0427", "0941-0429", "0941-0424", "0941-0430", "0941-0433", "0941-0484", "0941-0487", "0941-0490"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["799999", "800003", "800057", "800061", "800062", "800064", "800066", "800074", "800111", "800115", "800472", "800474"], "spl_id": ["36ea94f6-f614-9531-e063-6294a90aae55"], "spl_set_id": ["aa268d3f-7389-4f25-801f-5d4825495f08"], "package_ndc": ["0941-0411-05", "0941-0411-06", "0941-0411-07", "0941-0411-04", "0941-0411-11", "0941-0413-05", "0941-0413-06", "0941-0413-07", "0941-0413-01", "0941-0413-04", "0941-0415-05", "0941-0415-06", "0941-0415-04", "0941-0415-07", "0941-0415-01", "0941-0409-06", "0941-0409-05", "0941-0409-07", "0941-0409-01", "0941-0457-08", "0941-0457-02", "0941-0457-05", "0941-0457-01", "0941-0459-08", "0941-0459-02", "0941-0459-05", "0941-0459-01", "0941-0426-52", "0941-0426-53", "0941-0426-55", "0941-0427-52", "0941-0427-53", "0941-0427-55", "0941-0429-52", "0941-0429-53", "0941-0429-55", "0941-0424-51", "0941-0424-52", "0941-0424-53", "0941-0424-55", "0941-0430-51", "0941-0430-52", "0941-0430-53", "0941-0430-55", "0941-0433-51", "0941-0433-52", "0941-0433-53", "0941-0433-55", "0941-0484-01", "0941-0487-01", "0941-0490-01"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "92931", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1141-2023", "product_description": "Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 5000 mL AMBU-FLEX ll Container with yellow pull ring, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA Product code L5B5193 NDC 0941-0411-07", "product_quantity": "22,112 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.", "recall_initiation_date": "20230811", "center_classification_date": "20230829", "termination_date": "20240716", "report_date": "20230906", "code_info": "Lot Y406734, Exp 31-Oct-2024"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0705-2022", "product_description": "Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tube, Rx Only, Manufactured for: Hi-Tech Pharmacal Co., Inc., Amityville, NY  11701, NDC 50383-341-35.", "product_quantity": "49,081 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 16695, Exp 4/30/2024"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1101-2016", "product_description": "All melatonin Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0991-2020", "product_description": "Triamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE DIACETATE [10ML] CMC 80 MG/ML INJ SUSP, For IM, IA, IT Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0634-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07162019+52686, Exp 4/11/2020; 11062019+53192, Exp 8/2/2020"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA063277"], "brand_name": ["DOXORUBICIN HYDROCHLORIDE"], "generic_name": ["DOXORUBICIN HYDROCHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-101", "63323-883"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DOXORUBICIN HYDROCHLORIDE"], "rxcui": ["1191138", "1790097", "1790099", "1790100"], "spl_id": ["89998b96-8ca7-4eb1-98a4-e533420d0e72"], "spl_set_id": ["e0349f98-42fa-4003-b6d8-a1db1401b0ef"], "package_ndc": ["63323-883-05", "63323-883-10", "63323-883-30", "63323-101-61"], "is_original_packager": [true], "unii": ["82F2G7BL4E"]}, "product_type": "Drugs", "event_id": "86765", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0105-2021", "product_description": "DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047.  NDC: 63323-883-05", "product_quantity": "16,986 vials", "reason_for_recall": "Cross Contamination with Other Products: trace amounts of octreotide found during testing", "recall_initiation_date": "20201117", "center_classification_date": "20201124", "termination_date": "20220825", "report_date": "20201202", "code_info": "Batch: 6120525, exp 11/2020"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1193-2022", "product_description": "Alprostadil/Papaverine/Phentolamine 60mcg/30mg/3mg/mL, 3mL-vial, Refrigerate, Tailor Made Compounding", "product_quantity": "32 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch #: 01042221A2, Exp 3/5/2022; 02192216A1, Exp 4/20/2022.", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2350 units", "code_info": "Lot #: a) 5/15/17 2305 81467S, BUD 7/29/2017; 5/22/17 1000 81467S, BUD 8/5/2017; 5/30/17 1549 81467S,BUD 8/13/2017.  b) 5/24/17 0307 169-81479S, BUD 7/23/2017; 5/18/17 0220 169-81479S, BUD 7/17/2017; 5/16/17 0306 169-81479S, BUD 7/15/2017;  6/5/17 0937 169-81479S, BUD 8/04/2017; 5/16/17 0314 445-81479S, BUD 7/15/2017; 5/16/17 0315 493-81479S, BUD 7/15/2017;  c) 5/15/17 2119 81461S, BUD 7/29/2017; 5/22/17 0922 81461S, BUD 8/5/2017; 5/30/17 1533 81461S, BUD 8/13/2017; 6/12/17 1846 81461S, BUD  8/26/2017; 6/5/17 0237 157-81461SB, BUD 8/4/2017.", "center_classification_date": "20170707", "distribution_pattern": "Nationwide with the United States", "state": "TX", "product_description": "QUELICIN (Succinylcholine Chloride) Injection, USP 20 mg/mL in a) 5 mL vial (NDC 15082-814-67), b) 7mL vial (NDC 15082-814-79), c) 10mL vial (NDC 15082-814-61), Repackaged by Advanced Pharm, 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404.", "report_date": "20170719", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0953-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77595", "termination_date": "20171206", "more_code_info": "", "recall_initiation_date": "20170622", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090858"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Major Pharmaceuticals", "Cardinal Health 107, LLC"], "product_ndc": ["0904-6665", "0904-6666", "0904-6667", "55154-3363", "55154-7992", "55154-7993"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["b6880b32-3ebc-4b0e-8a84-d513f3e401af", "c5f4a9a6-33bb-4e3a-a8ac-ca41e8355b40"], "spl_set_id": ["36f74fdf-0dae-47a0-a7ea-e64ac91cd88f", "41844c21-9e2a-4332-a8ff-9b71ae9032b0"], "package_ndc": ["0904-6665-61", "0904-6666-61", "0904-6667-61", "55154-3363-0", "55154-7992-0", "55154-7993-0"], "original_packager_product_ndc": ["67877-222", "67877-223", "67877-224", "0904-6665", "0904-6666", "0904-6667"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"], "upc": ["0055154799300", "0055154799201", "0055154336307"]}, "product_type": "Drugs", "event_id": "97777", "recalling_firm": "The Harvard Drug Group LLC", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "US Nationwide.", "recall_number": "D-0031-2026", "product_description": "Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61 (Blister pack), NDC 55154-3363-0 (Outer Bag).", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .", "recall_initiation_date": "20251010", "center_classification_date": "20251017", "report_date": "20251029", "code_info": "Lot # M04989A [Bag], M04989 [Blister Pack], Exp Date: 02/2026; Lot # M05056A [Bag], M05056 [Blister Pack], Exp Date: 04/2026; Lot # M05150A [Bag], M05150 [Blister Pack], Exp Date: 07/2026; Lot # M05312A [Bag], M05312 [Blister Pack], and M05342A [Bag], M05342 [Blister Pack], Exp Date: 01/2027.", "more_code_info": ""}, {"country": "United States", "city": "Rockford", "address_1": "4901 Hiawatha Dr", "reason_for_recall": "Presence of Particulate Matter", "address_2": "", "product_quantity": "2,455 vials", "code_info": "Lot #: 7801221, 7801222, Exp 03/16", "center_classification_date": "20150814", "distribution_pattern": "Nationwide and Puerto Rico", "state": "IL", "product_description": "Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL  61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5.", "report_date": "20150826", "classification": "Class I", "openfda": {}, "recalling_firm": "Mylan Institutional LLC", "recall_number": "D-1333-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71004", "termination_date": "20160520", "more_code_info": "", "recall_initiation_date": "20150323", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90774", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Distributed Nationwide in the USA to the following States: AZ, CA, GA, ID, IN, MT, NM, NV, OR, TX, UT", "recall_number": "D-1468-2022", "product_description": "Colgate Anticavity Fluoride Toothpaste, OPTIC WHITE with CHARCOAL COOL MINT PASTE, Net Wt. 4.2 OZ. UPC 0 35000 97872 1. Dist. by: Colgate-Palmolive Company New York, NY 10022 U.S.A.", "product_quantity": "840 packages", "reason_for_recall": "cGMP deviation: Product held outside of appropriate temperature storage conditions.", "recall_initiation_date": "20220810", "center_classification_date": "20220829", "report_date": "20220907", "code_info": "SKUs 998909 distributed to Family Dollar retail stores in AZ, CA, GA, ID, IN, MT, NM, NV, OR, TX, UT", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0967-2019", "product_description": "Dr. King's Natural Medicine Stress Control, 59 mL, (liquid/liquide), DIN-HM 80041740 UPC 357955180524", "product_quantity": "3883 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 011916A Exp. 01/19; 081516G Exp. 08/19"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "64 units", "code_info": "Rx #'s:  T0372867  T0387431  T0388104  T0389467    T0389651  T0389841  T0391671  T0394240    T0395182  T0395583  T0396607  T0397069  T0397176  T0398192  T0399822  T0399900  T0400079  T0400081  T0400293  T0400444  T0400658  T0400794  T0400806  T0400871  T0401635  T0401644  T0401957  T0402166  T0402388  T0402390  T0402553  T0402656  T0402943  T0403559  T0405372  T0405460  T0406116  T0406555  T0406565  T0406984  T0407064  T0407383  T0407394  T0407440  T0407793  T0408122  T0408306  T0408399  T0408744  T0409050  T0409093  T0409107  T0409169  T0409178  T0396714  T0394672    T0395926  T0394672  T0394672  T0398564  T0394672", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TROCAR KIT, STERILE DISPOSABLE**  DEVICE\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1 PELLET  \t2 KIT  \t  \t  \t3 KIT  \t4 KIT  \t5 KITS  \t6 KIT  (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1631-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0523-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17", "product_quantity": "4,921 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2300076, Exp Date: 12/31/2025"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "620 ml", "code_info": "All lots distributed between November 2014 and May 2015;  02232015@72, 5/24/2015; 02252015@60, 5/26/2015; 03112015@55, 6/9/2015; 03122015@99, 6/10/2015; 03172015@67, 6/15/2015; 03312015@74, 6/29/2015;   05052015@34, 8/3/2015; 04292015@21, 7/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "LIPO-VITE III, Injection Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1689-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Key Colony Beach", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "62543", "recalling_firm": "Coral Rock Man, Inc.", "address_1": "420 11th Street", "address_2": "N/A", "postal_code": "33051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to three distributors/wholesalers and then distributed nationwide by internet and retail sales.", "recall_number": "D-039-2013", "product_description": "Z-ROCK All Natural Male Supplement. 1 capsule blister pack, UPC 0 00309 50792 7, Distributed by Zrock USA PO Box 668297, Pompano Beach, FL 33066", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Products tested positive for Sildenafil and analogs of Sildenafil.", "recall_initiation_date": "20120716", "center_classification_date": "20121101", "termination_date": "20151130", "report_date": "20121107", "code_info": "All Lots All codes.", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1421-2016", "product_description": "5 mcg/mL Fentanyl Citrate and 0.04% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Yellow Smiths Medical Cassette, flow stop free-flow protection, Service Code 2K8809, Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-809-48", "product_quantity": "2,256 Medical Cassettes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number 160460023M , Exp. Date 5/7/2016 ;  Lot Number 160460024M , Exp. Date 5/7/2016 ;  Lot Number 160460025M , Exp. Date 5/7/2016 ;  Lot Number 160460328M , Exp. Date 5/7/2016 ;  Lot Number 160540052M , Exp. Date 5/15/2016 ;  Lot Number 160600338M , Exp. Date 5/21/2016 ;  Lot Number 160600339M , Exp. Date 5/21/2016 ;  Lot Number 160600340M , Exp. Date 5/21/2016 ;  Lot Number 160600341M , Exp. Date 5/21/2016 ;  Lot Number 160680065C , Exp. Date 5/29/2016 ;  Lot Number 160750039C , Exp. Date 6/5/2016 ;  Lot Number 160750040C , Exp. Date 6/5/2016 ;  Lot Number 160750041C , Exp. Date 6/5/2016 ;  Lot Number 160770040C , Exp. Date 6/7/2016 ;  Lot Number 160880030C , Exp. Date 6/18/2016 ;  Lot Number 160880031C , Exp. Date 6/18/2016 ;  Lot Number 160880032C , Exp. Date 6/17/2016 ;  Lot Number 160880033C , Exp. Date 6/18/2016 ;  Lot Number 160880034C , Exp. Date 6/18/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72177", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0588-2016", "product_description": "Ephedrine Sulfate 5 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 25 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.", "product_quantity": "4123", "reason_for_recall": "Stability data does not support expiry.", "recall_initiation_date": "20150819", "center_classification_date": "20160127", "termination_date": "20170509", "report_date": "20160203", "code_info": "All lots with expiration dates up to 11/17/2015"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208066"], "brand_name": ["LURASIDONE HYDROCHLORIDE"], "generic_name": ["LURASIDONE HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-578", "47335-684", "47335-639", "47335-685", "47335-579"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LURASIDONE HYDROCHLORIDE"], "rxcui": ["1040031", "1040041", "1235247", "1297278", "1431235"], "spl_id": ["2ebf334e-6f66-4ef7-b0ca-9d21ccb3165e"], "spl_set_id": ["6d97d871-66d3-4ed8-bbc5-0620e9f69ae5"], "package_ndc": ["47335-578-83", "47335-578-81", "47335-578-13", "47335-684-83", "47335-684-81", "47335-684-13", "47335-639-83", "47335-639-81", "47335-639-13", "47335-685-83", "47335-685-81", "47335-685-13", "47335-579-83", "47335-579-81", "47335-579-13"], "is_original_packager": [true], "unii": ["O0P4I5851I"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0266-2024", "product_description": "Lurasidone Hydrochloride Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by:  Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-639-83.", "product_quantity": "11,400 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0620A  Exp. 05/31/2025"}, {"status": "Terminated", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90813", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-1495-2022", "product_description": "Lidocaine Hydrochloride Jelly USP, 2%,  Sterile, 30mL tube, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-711-31", "product_quantity": "82,689 tubes", "reason_for_recall": "cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.", "recall_initiation_date": "20220831", "center_classification_date": "20220906", "termination_date": "20240618", "report_date": "20220914", "code_info": "Lot # 9J36A, 9J36B, 9J39A, 9J39B, 9J39C, 9J39D, 9J39E, 9J42B, 9J42C, Exp 8/31/2022; 9K62A, 9K62B, 9K62C, Exp 9/30/2022; 9M04A, 9M04B, Exp 11/30/2022"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0737-2021", "product_description": "Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-5145-01", "product_quantity": "434,229 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 31325852B, 31325985B, exp. date 10/2021; 31326349B, exp. date 01/2022; 31326873B, exp. date 03/2022; 31326995B, exp. date 05/2022  31327158B, exp. date 06/2022; 31328946B, 31329180B, exp. date 05/2023."}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0292-2020", "product_description": "S-TESTOSTERONE ULTRA 250MG/ML MDV IN SESAME OIL (TEST CYP 200MG/TEST PROP 25MG/NANDROLONE DECA 25MG) Rx Only, 10ml glass vial Red Mountain Compounding Rx.", "product_quantity": "10x10 ml glass vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:S07132019DT@01, Exp 10/13/19;S07312019DH@05, Exp 10/31/19  S06122019DT@09, Exp 9/12/19;"}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64716", "recalling_firm": "Pallimed Solutions", "address_1": "400 W Cummings Park", "address_2": "", "postal_code": "01801-6519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-868-2013", "product_description": "Gentamicin Sulfate Irrigation, compounded by Pallimed Solutions Pharmacy, Woburn, MA", "product_quantity": "", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130325", "center_classification_date": "20130809", "termination_date": "20130821", "report_date": "20130821", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076658"], "brand_name": ["FLUCONAZOLE"], "generic_name": ["FLUCONAZOLE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-143", "55111-144", "55111-145", "55111-146"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUCONAZOLE"], "rxcui": ["197698", "197699", "197700", "197701"], "spl_id": ["69e67aa4-a859-7ab0-79df-d9bf8489998d"], "spl_set_id": ["d7fa1d79-4cd3-4a55-b74b-b31e82e616a3"], "package_ndc": ["55111-143-30", "55111-143-01", "55111-143-05", "55111-143-79", "55111-143-78", "55111-144-30", "55111-144-01", "55111-144-05", "55111-144-79", "55111-144-78", "55111-145-71", "55111-145-12", "55111-146-30", "55111-146-01", "55111-146-05", "55111-146-79", "55111-146-78"], "is_original_packager": [true], "upc": ["0355111145127"], "nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["8VZV102JFY"]}, "product_type": "Drugs", "event_id": "76122", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0451-2017", "product_description": "Flucanozole Tablets, USP, 150 mg, 12x1 Blister cards, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India --- NDC 55111-145-12", "product_quantity": "59,440 blister cards", "reason_for_recall": "Failed Dissolution Specifications; 18 month stability time point", "recall_initiation_date": "20161228", "center_classification_date": "20170130", "termination_date": "20171019", "report_date": "20170208", "code_info": "C500222, C500515, and C500517, exp 12/2016, C502343, exp 03/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065499"], "brand_name": ["AMPICILLIN"], "generic_name": ["AMPICILLIN SODIUM"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-111", "55150-112", "55150-113", "55150-114"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["AMPICILLIN SODIUM"], "rxcui": ["1721473", "1721474", "1721475", "1721476"], "spl_id": ["5dbaef00-a574-4294-8422-598bb4018b27"], "spl_set_id": ["b7bf2897-8272-4c7d-84e9-6fbba0ea63fa"], "package_ndc": ["55150-111-10", "55150-112-10", "55150-113-10", "55150-114-20"], "is_original_packager": [true], "upc": ["0355150113101", "0355150111107", "0355150114207", "0355150112104"], "unii": ["JFN36L5S8K"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1009-2022", "product_description": "Ampicillin for Injection, USP, 1 g per vial, 10-count box, Rx only, Distributed by: Auromedics Pharma, NDC 55150-113-10", "product_quantity": "10 cartons/10 vials each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA074249"], "brand_name": ["CLOBETASOL PROPIONATE"], "generic_name": ["CLOBETASOL PROPIONATE"], "manufacturer_name": ["Sun Pharmaceutical Indutries, Inc."], "product_ndc": ["51672-1258", "51672-1294", "51672-1259"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["CLOBETASOL PROPIONATE"], "rxcui": ["861434", "861448", "861495"], "spl_id": ["3bce3d34-1e96-3d4c-e063-6294a90af844"], "spl_set_id": ["4a761afb-a48a-4a5a-8700-ad93601a260f"], "package_ndc": ["51672-1294-1", "51672-1294-2", "51672-1294-3", "51672-1258-1", "51672-1258-2", "51672-1258-6", "51672-1258-3", "51672-1259-1", "51672-1259-2", "51672-1259-6", "51672-1259-3"], "is_original_packager": [true], "upc": ["0351672129422"], "unii": ["779619577M"]}, "product_type": "Drugs", "event_id": "89241", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.", "recall_number": "D-0375-2022", "product_description": "Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3", "product_quantity": "96 tubes", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria", "recall_initiation_date": "20211215", "center_classification_date": "20220118", "termination_date": "20231204", "report_date": "20220119", "code_info": "Lot# AC13786, exp. date DEC 2022"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "292,320 cartons", "code_info": "Lot #: 10116040, Exp 6/30/2013; 10119871, Exp 7/31/2013; 10122275, Exp 9/30/2013.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "Theraflu Sugar-Free Nighttime Severe Cold & Cough (acetaminophen 650 mg, diphenhydramine hydrochloride 25 mg, phenylephrine hydrochloride 10 mg) powder packets, Honey Lemon flavor, 6-count packets per carton, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ  07054-0622, NDC 0067-6318-06, UPC 3 0043-6318-06 0.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-754-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0319-2023", "product_description": "TPN 107gm/AA, 200gm/DEX, 50gm/LIP 2250mL, (b) 108GM/AA, 330GM/DEX 3000ML, (c) 108GM/AA, 330GM/DEX, 60GM/LIP 3000ML, (d) 37GM/AA, 160GM/DEX 1450ML, (e) 37GM/AA, 160GM/DEX, 25GM/LIP 1450ML, (f) 74-100GM  OF PROTEIN B4197 74 Gm, (g) 75GM/AA, 200GM/DEX, 43GM/LIP 2500ML, (h) 90GM/AA ; 255GM/DEX ; 50GM/LIP 3500 ml, (i) 90GM/AA ; 255GMDEX 3500 ml, (j) TPN AA 100GM DEX: 320GM LIP: 50GM 2400ML, (k) TPN AA 30GM DEX: 145GM 1210ML, (l) TPN AA 30GM DEX: 145GM LIP: 35GM 1210ML, (m)TPN AA  42GM DEX: 432GM 2070ML, (n) TPN AA 50GM DEX: 130GM 2500ML, (o) TPN AA 55GM DEX:180GM 1000ML, (p) TPN AA 70GM DEX:290GM 2100ML, (q) TPN AA 70GM DEX:290GM 2500ML, (r) TPN AA 80GM DEX:200GM 1900ML, (s) TPN AA 80GM DEX:200GM LIP:38GM 1900ML, (t) TPN AA 30GM ; DEX 82GM ;  IN 890 ml, (u) TPN AA 30GM ; DEX 82GM ; LIP 18GM IN 890 ml, Rx Only, use with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "111 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 24-31, 2022"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-1011-2013", "product_description": "Zinc Sulfate 1 mg/ml INJECTABLE, all configurations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "02082013@9, 06102013@16", "more_code_info": ""}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0332-2020", "product_description": "Viatrexx-Articula, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0031, NDC 73069-037-41.", "product_quantity": "69 vials", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00008, Exp. May: 2020"}, {"status": "Ongoing", "city": "Thousand Oaks", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103353"], "brand_name": ["NEUPOGEN"], "generic_name": ["FILGRASTIM"], "manufacturer_name": ["Amgen, Inc"], "product_ndc": ["55513-209", "55513-530", "55513-546", "55513-924"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["FILGRASTIM"], "rxcui": ["727535", "727537", "727544", "727545", "1649944", "1649946", "1649963", "1649964"], "spl_id": ["cc41b9c3-f2de-416f-9396-acdc8dac69b9"], "spl_set_id": ["97cc73cc-b5b7-458a-a933-77b00523e193"], "package_ndc": ["55513-530-01", "55513-530-10", "55513-530-20", "55513-546-01", "55513-546-10", "55513-546-20", "55513-924-01", "55513-924-10", "55513-924-91", "55513-924-20", "55513-209-01", "55513-209-10", "55513-209-91", "55513-209-20"], "is_original_packager": [true], "upc": ["0355513530101", "0355513546102"], "nui": ["M0024696", "N0000009451", "N0000175666"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "unii": ["PVI5M0M1GW"]}, "product_type": "Drugs", "event_id": "96325", "recalling_firm": "Amgen, Inc.", "address_1": "1 Amgen Center Dr", "address_2": "N/A", "postal_code": "91320-1730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia, France/French Guiana, Germany, Ireland, Italy/San Marino, Netherlands, Poland, Spain/Andorra, Sweden, Finland, Switzerland/Liechtenstein, United Kingdom of Great Britain and Northern Ireland, Ireland, Denmark, Canada, Hong Kong, Philippines, Israel, Malaysia, Saudi Arabia, Gibraltar.", "recall_number": "D-0285-2025", "product_description": "Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-530-01 (vial), NDC 55513-530-10 (box).", "product_quantity": "313,620 Vials", "reason_for_recall": "Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.", "recall_initiation_date": "20250227", "center_classification_date": "20250318", "report_date": "20250326", "code_info": "Lot #: 1147300, 1147300A, Exp.: 2/28/2025; 1152064, Exp.:3/31/2025; 1154734, 1156806, Exp.: 8/31/2025; 1159109, Exp.: 10/31/2025; 1163909, Exp.: 2/28/2026; 1164631, Exp.: 5/31/2026; 1171366, 1182097, Exp.:8/31/2026; 1176114, Exp.: 2/28/2027; 1182094, Exp.:7/31/2027."}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0065-2016", "product_description": "CHORIONIC GONADOTROPIN, Injectable Solution, 5000 UNITS/0.1 mL, vial sizes: 5 mL; 6 mL; 8 mL; 10 mL,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "9 (5mL) vials, 2 (6mL) vials, 8 (8mL) vials, 2 (10mL) vials", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12292014@35, t12192014@15, t12162014@29, t10232014@24, t09162014@29, t09032014@6, t07252014@16, t07142015@6, t07022015@8, t06152015@32, t05272015@33, t04282015@11, t04162015@34, t04092015@8, t04022015@30, t02262015@24, t02032015@21, and t01232015@10"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-656-2013", "product_description": "Mitomycin 0.04% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "50ml total", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABDAGAD:25, Exp date: 4/20/2013 and Lot number CABDAGAD:84, Exp date: 4/20/2013."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0141-2023", "product_description": "Ketorolac Tromethamine Ophthalmic Solution, 0.5%, Packaged as a) 10 mL dropper bottle, NDC 17478-209-11; (b) 3 mL dropper bottle, NDC 17478-209-19; (c) 5 mL dropper bottle, NDC 17478-209-10; Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.", "product_quantity": "314,543 10ml,3ml, 5ml bottles", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: (a) 1A09A, EXP 12/31/2022; 1H01A, EXP 7/31/2023 ; (b) 1E32A, EXP 4/30/2023; 1F45A, EXP 5/31/2023; 1H99A, EXP 7/31/2023; 1K84A, EXP 9/30/2023;  (c) 0L40A, EXP 10/31/2022; 1B38A, EXP 1/31/2023; 1E12A, EXP 4/30/2023; 1F41A, EXP 5/31/2023; 1G73A, 1G68A, EXP 6/30/2023; 1H08A, 1H12A, EXP 7/31/2023"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94922", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0595-2024", "product_description": "Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1725-01 (vial), NDC 70710-1725-06 (outer box).", "product_quantity": "12720 vials", "reason_for_recall": "Cross contamination with other products", "recall_initiation_date": "20240702", "center_classification_date": "20240710", "report_date": "20240717", "code_info": "Lot #: L300220, Exp. 05/31/2025."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0547-2017", "product_description": "HYDROQUINONE CREAM  in all strengths including 4%, 5%,6%, 7%, 8%, HYDROQUINONE 5%/KOJIC ACID 3% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8a5df7d8-ad17-44d7-9c56-44fa2aaa0852"], "spl_set_id": ["fc2bd95d-a7bc-4ab5-bffa-f5059cb8eb63"], "package_ndc": ["70710-1129-1", "70710-1129-2", "70710-1129-4", "70710-1130-1", "70710-1130-2", "70710-1130-4", "70710-1131-1", "70710-1131-2", "70710-1131-4", "70710-1132-1", "70710-1132-2", "70710-1132-4", "70710-1133-1", "70710-1133-2", "70710-1133-4"], "is_original_packager": [true], "upc": ["0370710112912", "0370710113216", "0370710113018"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "96626", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA", "recall_number": "D-0361-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1", "product_quantity": "3144 bottles, pack size: 100's Count", "reason_for_recall": "CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit", "recall_initiation_date": "20250403", "center_classification_date": "20250410", "report_date": "20250416", "code_info": "Lot #: Z400069, Exp.: 12/31/2025"}, {"country": "United States", "city": "Brookfield", "address_1": "19035 W. Capitol Dr", "reason_for_recall": "Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.", "address_2": "Suite 105", "product_quantity": "30 mL", "code_info": "Lot # / Beyond Use Date: 05012014@36 / 05/15/14", "center_classification_date": "20140703", "distribution_pattern": "WI only", "state": "WI", "product_description": "Diphenhydramine (Alcohol Base) 25 mg / 0.5 mL Solution, 30 mL bottle, Rx only, MD Custom Rx, 19035 W. Capitol Dr., Ste. 105, Brookfield, WI  53045", "report_date": "20140709", "classification": "Class II", "openfda": {}, "recalling_firm": "Brookfield Prescription Center Inc. dba MD Custom Rx", "recall_number": "D-1417-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "68616", "termination_date": "20150522", "more_code_info": "", "recall_initiation_date": "20140530", "postal_code": "53045", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Brooklyn", "address_1": "908 Dean St", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.", "address_2": "", "product_quantity": "Unknown", "code_info": "All lots", "center_classification_date": "20160711", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NY", "product_description": "FARSER KAI YEUNG PILL, packaged in a bottle within a box,  Made in The Peoples Republic of China, remaining labeling contains Chinese characters.", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Murray International Trading Co., Inc.", "recall_number": "D-1355-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "74017", "termination_date": "20180614", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "11238-3204", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "40", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Midazolam (PF) 5mg/ml 25 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC # 45183-0138-67", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1267-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66083", "recalling_firm": "South Coast Specialty Compounding, Inc.", "address_1": "9257 Research Dr", "address_2": "N/A", "postal_code": "92618-4286", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "CA, IN", "recall_number": "D-1026-2013", "product_description": "Multitrace-5 Concentrate (Trace Elements -5 Conc Injection) Solution, Sterile 10mL Multiple Dose Vial, For Slow IV Administration After Dilution Only, Park Compounding, Irvine, CA", "product_quantity": "82 vials", "reason_for_recall": "Lack of Assurance of Sterility: Park Compounding is recalling Methylcobalamin 5 mg/mL, Multitrace-5 Concentrate, and Testosterone Cypionate (sesame oil) for injection due to lack of sterility assurance.", "recall_initiation_date": "20130823", "center_classification_date": "20130912", "termination_date": "20131017", "report_date": "20130918", "code_info": "Lot #05212013@20 and Lot#03212013@6, Exp 11/17/2013", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "39 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Testosterone Injection 100mg/mL, 200mg/mL, 300mg/mL, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0459-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0675-2022", "product_description": "Desonide Ointment, 0.05%, packaged in a) 15 g tubes, NDC 52565-038-15; b) 60 g tubes, NDC 52565-038-60, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.", "product_quantity": "36,426 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15495, Exp. 4/30/2022; 16955, Exp. 5/31/2023; b) 15249, 15250, 15446, Exp. 3/31/2022; 15495, Exp. 4/30/2022; 16377, Exp. 1/31/2023"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016673"], "brand_name": ["DEXTROSE"], "generic_name": ["DEXTROSE MONOHYDRATE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0017", "0338-0023"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DEXTROSE MONOHYDRATE"], "rxcui": ["1795477", "1795480", "1795481", "1795607", "1795609", "1795610", "1795612", "1795616", "1795618"], "spl_id": ["31bb4a5f-733e-4354-9fbf-138dede4db0f"], "spl_set_id": ["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"], "package_ndc": ["0338-0017-10", "0338-0017-41", "0338-0017-11", "0338-0017-31", "0338-0017-48", "0338-0017-18", "0338-0017-38", "0338-0017-02", "0338-0017-03", "0338-0017-04", "0338-0023-02", "0338-0023-03", "0338-0023-04"], "is_original_packager": [true], "unii": ["LX22YL083G"]}, "product_type": "Drugs", "event_id": "70770", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0426-2015", "product_description": "5% Dextrose Injection, USP, 1000mL in VIAFLEX Plastic Container, Rx only, Manufactured by Baxter Healthcare Corp., North Cove, North Carolina Facility Highway 221 North, Marion, NC 28752 for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015. NDC 0338-0017-04", "product_quantity": "48,874", "reason_for_recall": "Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.", "recall_initiation_date": "20150318", "center_classification_date": "20150325", "termination_date": "20160224", "report_date": "20150401", "code_info": "Lot #: C926899, Exp 7/31/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1059-2018", "product_description": "Hyaluronidase 150 units/mL 1ml. Rx Only. Packaged in 1 mL syringes. Refridgerate. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "442 1-ml syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lots: 58895:42 Use By: 06/27/2018; 58856:42 Use By: 06/21/2018;"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0975-2020", "product_description": "MIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Refrigerate, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0231-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 06242019+52513, Exp 1/23/2020; 06242019+52515, Exp 1/23/2020; 07252019+52756, Exp 2/23/2020; 08212019+52823, Exp 3/21/2020; 10012019+52989, Exp 5/1/2020; 11062019+53194, Exp 6/6/2020"}, {"country": "United States", "city": "Roswell", "address_1": "1400 Holcomb Bridge Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products; The affected lots were found to be contaminated with bacterium, Burkholderia cepacia complex.", "address_2": "", "product_quantity": "5268 Cassettes", "code_info": "SKU #12977-00 (Cassette - 1 Liter), Lot #: SA1229ANB; b) SKU #12979-00 (E-Cassette - 1.2 Liters), Lot #: SA1229ANA, Exp 08/13", "center_classification_date": "20120712", "distribution_pattern": "Nationwide and Canada", "state": "GA", "product_description": "Kleenex Luxury Foam Hand Sanitizer, (Benzalkonium Chloride 0.1%), in a) 1 Liter (33.8 fl oz.), b) 1.2 Liters (40.5 fl oz.) Cassettes, Distributed by Kimberly Clark, LLC, Roswell, GA 30076", "report_date": "20120718", "classification": "Class II", "openfda": {}, "recalling_firm": "Kimberly-Clark Corporation", "recall_number": "D-1414-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "62418", "termination_date": "20130409", "more_code_info": "", "recall_initiation_date": "20120614", "postal_code": "30076", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0077-2020", "product_description": "NEOstigmine Methylsulfate (PF), 3 mg/3 mL (1 mg/mL), 3 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321677847", "product_quantity": "7685 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M010"], "brand_name": ["NIGHTTIME SLEEP AID"], "generic_name": ["DIPHENHYDRAMINE HCL"], "manufacturer_name": ["Wal-Mart Stores Inc"], "product_ndc": ["49035-330"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["DIPHENHYDRAMINE HYDROCHLORIDE"], "rxcui": ["1248354"], "spl_id": ["2bc5819a-1b5d-44d7-a788-bb7e2f4ba97e"], "spl_set_id": ["6e398d21-6cfa-4f9b-9219-0cd949e88266"], "package_ndc": ["49035-330-45", "49035-330-02", "49035-330-96", "8113117595"], "is_original_packager": [true], "upc": ["0681131171731", "681131175951"], "unii": ["TC2D6JAD40"]}, "product_type": "Drugs", "event_id": "83315", "recalling_firm": "LNK International, Inc.", "address_1": "55 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-1630-2019", "product_description": "Equate Night-time Sleep Aide (Diphenhydramine HCl), 50 mg, Alcohol Free, Berry Flavor, 12 Fl. Oz. (354 mL), OTC, Distributed by: Walmart Stores, Inc., Bentonville, AR 72716, NDC 49035-330-02, UPC 6 8113117595 1", "product_quantity": "P300456, P300475 and P300489 (Total - 13,500 liters) and P300482 - 3,600 liter", "reason_for_recall": "Microbial contamination of non-sterile product", "recall_initiation_date": "20190710", "center_classification_date": "20190806", "termination_date": "20230609", "report_date": "20190807", "code_info": "Lot #: P300456, P300475,P300482, P300489, Exp 09/30/2020"}, {"status": "Terminated", "city": "Henrico", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040388"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-614"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["966571"], "spl_id": ["5e30cfd3-9310-41a0-966e-dd22ff88379e"], "spl_set_id": ["f34904dc-c945-4de4-8594-34e4f4ac1983"], "package_ndc": ["63323-614-00", "63323-614-01"], "is_original_packager": [true], "upc": ["0363323614003"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "76863", "recalling_firm": "Mckesson Medical Surgical", "address_1": "9954 Mayland Dr", "address_2": "N/A", "postal_code": "23233-1464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0668-2017", "product_description": "hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL  60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.", "product_quantity": "98 vials", "reason_for_recall": "Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.", "recall_initiation_date": "20170308", "center_classification_date": "20170412", "termination_date": "20240819", "report_date": "20170419", "code_info": "Lot #s: 6114311, 6114717, Exp 05/18", "more_code_info": ""}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "529 vials", "code_info": "Lot #: a) Magnesium Sulfate 50%: 20130130-F, Exp 4/30/2013; 20130128-F, Exp 4/28/2013; 20130221-T, Exp 5/21/2013; b) MAGNESIUM SULFATE 50% 50 mL: 20130322-E, Exp 6/22/2013; 20130219-C, Exp 5/19/2013; 20130307-A, Exp 6/7/2013; 20130404-G, Exp 7/4/2013; c) Magnesium Sulfate PF 50% 2 mL: 20130227-F, Exp 5/27/2013; 20130312-G, Exp 6/12/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Magnesium Sulfate Injection, all strengths and all presentations including a) Magnesium Sulfate 50%; b) MAGNESIUM SULFATE 50% 50 mL, c) Magnesium Sulfate PF 50% 2 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-384-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0169-2015", "product_description": "Vancomycin 50 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "10 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06102014@39, Exp 9/8/2014", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0258-2017", "product_description": "Glucosamine 200 mg/mL (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "30 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 10192016D (10/22/2016)."}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1603-2019", "product_description": "Herpes-V Balm, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1128-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride 50 mg/250mL (200mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043. NDC:72196-7039-1", "product_quantity": "340 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260038, Exp 10/3/2023.              ;"}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0677-2021", "product_description": "Goose Creek Hand Sanitizer aloe Dragonfruit Splash, Anti-Bacterial Spray, 3.38 FL. OZ. (100 mL), Goose Creek www.GooseCreekCandle.com, 1498 S. Wallace Wilkinson Blvd., Liberty, KY 42539, UPC 8 18489 01332 5", "product_quantity": "1,296 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20258", "more_code_info": ""}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-119-2013", "product_description": "Isovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "7055 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205927"], "brand_name": ["PRASUGREL"], "generic_name": ["PRASUGREL"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5185", "0378-5186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRASUGREL HYDROCHLORIDE"], "rxcui": ["855812", "855818"], "spl_id": ["9e234352-49b7-46e3-bc59-acf63e0a7a14"], "spl_set_id": ["41a4e332-6725-4cb7-940a-8291cf56cfe4"], "package_ndc": ["0378-5185-93", "0378-5186-93"], "is_original_packager": [true], "upc": ["0303785185932"], "unii": ["G89JQ59I13"]}, "product_type": "Drugs", "event_id": "96369", "recalling_firm": "MYLAN PHARMACEUTICALS INC", "address_1": "1311 Pineview Dr", "address_2": "N/A", "postal_code": "26505-3276", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0280-2025", "product_description": "Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93", "product_quantity": "N/A", "reason_for_recall": "Failed Dissolution Specifications - low dissolution results", "recall_initiation_date": "20250225", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot # 3211073, 3211074, 3211075, Exp 4/30/2026"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0195-2019", "product_description": "Trimix T 101 Alprostadil/Papverine/Phentolamine 5.9 mcg/17.65 mg/0.59 mcg per mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1336-05", "product_quantity": "20 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05312018:22 Discard by: 6/30/2018"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0087-2021", "product_description": "DCL T Shampoo for Hair and Body ( Solution Coal Tar U.S.P. 3% and 0.6% Coal Tar), 300 ml/ 10.1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 3574865069947", "product_quantity": "1,225 bottles", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot #: DW913-9, Exp. Date Apr-22"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0156-2015", "product_description": "Tri-mix ST2, 30 mg/3 mg/100 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "200 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06252014@33, Exp 9/23/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Fort Collins", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "66402", "recalling_firm": "Tolmar, Inc.", "address_1": "701 Centre Ave", "address_2": "N/A", "postal_code": "80526-1843", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-66402-001", "product_description": "Ketoconazole Shampoo, 2%, Manufactured by TOLMAR Inc., Fort Collins, CO for Sandoz Inc., Princeton, NJ --- NDC 0781-7090-04.", "product_quantity": "391,055 bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20130923", "center_classification_date": "20131018", "termination_date": "20140410", "report_date": "20131030", "code_info": "Lots: 6111A exp 8/14, 6191A exp 10/14, 5523A exp1/14, 5617A exp 2/14, 5619A exp2/14, 5660A exp 3/14, 5689A exp 3/14, 5690A exp 3/14, 6114A exp 9/14, 6115A exp 9/14,6118A exp 9/14, 6122A exp 9/14, 5307A exp 8/13, 5391A exp 10/13, 5393A exp 10/13, 5392A exp 10/13, 5394A exp 10/13, 5396A exp 11/13, 5430A exp 11/13, 5431A exp 11/13, 5432A exp 11/13, 5434A exp 11/13, 5578A exp 11/13, 5491A exp 11/13, 5492A exp 11/13, 5493A exp 12/13, 5494A exp 12/13, 5531A exp 1/14  5661A exp 3/14, 5490A exp 11/13, 5533A exp 2/14, 5495A exp 12/13, 5534A exp 2/14, 5535A exp 2/14, 5621A exp 2/14, 5728A exp 3/14, 6117A exp 9/14, 6113A exp 9/14, 5776A exp 4/14, 6112A exp 8/14, 6119A exp 9/14, 6192A exp 10/14,and 6123A exp 10/14"}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0226-2016", "product_description": "TRIEST 70/20/10  ( Estriol USP / Estradiol USP (E2) / Estrone (E1) Triturate) [909] 12.5MG/ML transdermal cream, dispensed in 1 mL prefilled amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "24 (1mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 12222014:81@25, Exp 6/20/2015"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1100-2022", "product_description": "Verapamil HCL, ampule, 2.5 mg/ML 2ML (5/pack), Rx only, MFG: Pfizer, NDC 04094-011-01", "product_quantity": "14 packs/ 5 per pack", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}]